Imaging cellular activities in an entire intact whole organ with light is a grand challenge in optical microscopy. To date, most passive clearing techniques were shown to transform brain, neuronal and embryo tissue into near transparent state for deep tissue imaging. Here, we expand these passive clearing protocols from neuronal tissue (brain and spinal cord) to other visceral organs such as liver and colon and further evaluate their "depthclearing performance" based on image contrast of endogenous fluorescence structures. We found that SeeDB achieves the highest depth in brain, 3DISCO is adept at clearing liver and spinal cord and ScaleViewA2 in colon. Overall, 3DISCO clears more rapidly than other agents but at a higher cost, while ScaleViewA2 is the most economical however at a slower rate. This study, for the first time, provide a direct evaluation of imaging depth, cost and time amongst passive tissue clearing protocols for different intact organs. In addition, we discuss the possible roles of tissue composition in clearing.
Introduction
Imaging both the structural and molecular information of intact organs at the cellular level is crucial to the understanding of disease progression and physiology. Modern laser fluorescence microscopy techniques use fluorescent markers that bind to specific cellular proteins so as to track the highlighted cells in intact organs [1] . These laser imaging techniques only operate well in low optical scattering biological samples (cell culture, zebrafish, c. elegans). The key contributing reason behind this is the large optical scattering in bulk tissue that severely limits optical imaging to a shallow depth [2, 3] . Light scattering in tissue can be defined by the transport mean free path (TMFP) [4] . TMFP depends on the scattering coefficient of the tissue that is in turn dependent on wavelength of light and homogeneity of refractive index. On-going efforts to reduce optical scattering (low TMFP) for whole organ imaging includes long wavelength imaging lasers (λ= 1.7 µm), adaptive optics and chemical clearing. Near-infrared pulse lasers emits longer wavelength photons that takes a longer mean free path and hence results in lower scattering coefficients [5] . Adaptive optics (AO) map the scattering coefficient of tissue (transmission matrix) and pre-compensate the incoming laser beam with an optical modulator [6, 7] to directly restore the optical point spread function, thus enabling deep imaging in tissue. Chemical optical clearing methods [8] [9] [10] [11] directly replace the interstitial components in tissues with a solution that matches the refractive index of tissue composition (i.e. lipids, n ~ 1.5), turning intact organs into a state of near transparency.
While the instrumentation-based techniques (imaging laser, adaptive optics) have the advantage of imaging living subjects, they have yet to achieve full imaging depth throughout entire organs [2] . Furthermore, each organ (tissue, colon to brain) are compose differently; connective tissue, interstitial fluids which makes it difficult to compensate without prior knowledge. On the other hand, chemical clearing techniques have achieve imaging depths throughout whole organs (brain, spinal etc) [3] by using agents and equipments that already exist in most biological research facilities. The recent surge in clearing protocols (3DISCO [9] , iDISCO [12] , SeeDB [8] , ScaleView [10] , ClearT [13] , CUBE[14] , PACT [15] , Clarity [11] etc) opens up a host of opportunities and increasing popularity amongst researchers for imaging neuronal tissue and embryos [8, 9, 11, 14] , but few protocols tackling non-neuronal adult tissue [12, 13, 15] . While new iDISCO [12] and PACT [15] showed significant progress in clearing other organs, their drawbacks are in the non-preservation of endogenous fluorescence. In general, all clearing protocols mainly differ [16] from each other in terms of reagents, cost, clearing time, protocol complexity and tissue optical transparency. Hence, it is unlikely that any single protocol is suitable for all experimental needs. Furthermore, the clearing of some rare diseased samples needs to be done at a calculated risk. To date, there has not been a quantitative study performed to compare the performance, cost and time efficiency in clearing with different protocols [16] .
In this paper, we addressed, for the first time, these practical concerns and compared the imaging depth of four optical clearing protocols (glycerol, SeeDB, SCALE, 3DISCO) across four organs (brain, spinal cord, colon and liver) on a high resolution multiphoton microscope.
The clearing protocols were chosen because they are passive methods made with commercially available reagents and equipment. We then conducted an assessment of the imaging depth of each optical clearing agent of image contrast using endogenous tissue fluorescence signals and root mean square. The imaging depth in each tissue was compared against the efficiency of each protocol with cost and incubation time. This comparison shall serves as a practical guide to researchers who plan to adopt passive chemical clearing.
Results

Imaging and contrast
Throughout the imaging sessions, the wavelength of the laser and other imaging parameters (photomultiplier tube: voltage, gain, offset) were kept constant. The excitation wavelength of 900 nm was chosen to excite green fluorescence protein (GFP) excitation and second harmonic generation (SHG) imaging. The imaging channels used to collect the signal include blue (filter BA410-455nm) for SHG from collagen fibers and green (filter BA495-540nm) for endogenous fluorescence and GPF signal. Laser power was gradually increased to compensate for absorption loss along the imaging depth. The step size between each frame in the z-stack is 1 µm. This allowed for relatively fast scanning of the samples, without impairing the resolution of the image greatly. The choice of a 1 µm step size results in a voxel dimension of 1x1x1 µm. In Fig.1 , we show, qualitatively, imaging performance using cross sectional views of 3D stacks of each tissue: liver, spinal cord, colon and brain. Control images (PBS solution) are shown in the inset. In non-GFP expressing samples tissue such as liver, auto-fluorescence from sinusoid structures and vasculture are visualized. From Fig.1 , it is apparent that the imaging performance have a larger variation for liver and spinal cord, but lower variation for colon and brain. Next we move to quantifying the imaging depth for each tissue sample.
Imaging Depth
Previous optical clearing studies use fluorescent particles [8] , the optical transmittance [10] , endogenous fluorescence [17] and coherence imaging [18] to quantify imaging depth. The full width half intensity maximum (FWHM) of fluorescence cells/particles measures imaging quality at different depths, and endogenous fluorescence (auto-fluorescence) and backscattered light provides imaging of tissues structures (collagen, elastin etc). Auto-fluorescence illuminates distinct structures (vasculature, villi etc) to provide contrast. Table 1 shows the tissue used in this study. In brain tissue, there is an abundant amount of GFP fluorescence cells, but these are sparsely distributed in spinal cord. For other visceral organs where GFP signals are not available, the vasculature in liver and villi distribution in colon serves as form of "negative" contrast. The quantification of contrast here is largely measured by a metric called root mean square (r.m.s) contrast. This is a common approach to measure contrast between objects without relying on spatial frequency content of the image [19] as shown in Eq. 1, where n is the number of pixels and I is the grayscale value. ScaleViewA2 showed a more consistent FWHM (16 ± 10 µm). Depth determined with FWHM is given as follows: Glycerol: 934 µm, 3DISCO: 650 µm, SCALE: 1500 µm, SeeDB:
1700 µm) and imaging depth with half of the maximum contrast is given as follows;
Glycerol: 346 µm, 3DISCO: 562 µm, SCALE: 691 µm, SeeDB: 934 µm. Imaging depth is decided at the point when contrast value has fallen by half of the maximum contrast (50%) at the tissue surface or that FWHM of fluorescent cells has broaden by more than twice, as shown in Fig. 2a ii). The imaging depths measured using the two metrics are plotted in Clearing liver tissue with glycerol, ScaleViewA2 and SeeDB rendered the appearance of the tissue slightly more white compared to the control sample. 3DISCO hardens liver tissue with an amber coloured glass appearance. None of the protocols were able to fully clear colon tissue over 300 µm which could be explained by tissue composition. Fig.3b shows the 3D reconstruction of tissues with the highest imaging depth in various tissues with brain using SeeDB whereas spinal cord, liver and colon with 3DISCO.
Discussion
At the heart of optical clearing is the reduction of the scattering coefficient. The clearing process is complex and makes use of mechanisms [3] such as dehydration of tissue, partial replacement of interstitial fluid, molecular structure of clearing agent (hydrophilic/lipophilic)
[20] and structural modification of collagen. The efficiency of each clearing process can be further complicated by different organs and tissue types that is difficult to predict experimentally. As the result, the mixture of clearing agents is assessed by their improvement of clearing time, increase optical transparency, compatibility with dyes and cell markers and also its viability to clear different tissue types. Hirshburg et al [20] showed that the optical clearing agent with high affinity to form hydrogen bridges to homogenized tissue refractive index correlate to high efficiency in optical clearing than index matching. More recent clearing compounds have targeted lipids to enhance clearing. For example, urea (ScaleView) removes lipids and maintains fluorescence proteins, however compromises the structural integrity of tissue. Hydrogel-based clearing (Clarity, PACT) replaces lipid with monomers that stabilized the tissue structure over a long time, but facilities the addition of proteins through monomers. Every iteration protocol tries to address shortcomings in the previously developed protocols, however, accompanied with drawbacks of its own. Based on the current trend, it is more likely to pick suitable protocols specific to organs instead of a multipurpose, low cost and high efficient clearing agent. In the future, it will be useful to combine live cellular level imaging techniques to study the uptake of new clearing agents at single cell level so as to determine the local effects of clearing agents.
Clearing agents -variation in organs
Out of four passive clearing protocol, we determined the optimal protocol for the adult visceral and neuronal organs. Our imaging results clearly demonstrate a significant variation between different organs. The effect may be attributed to the different tissue layers in each organs. For example, brain is mainly comprise of neuronal networks and small vasculatures that has not collagen. However, in spinal cord, there is a network of connective tissues (collagen) with nerve bundles (myelinated) that increases scattering. In lower colon, the composition is much more complex where there are multiple separate layers of columnar epithelial layers (villi), muscle cells and connective tissues that increases optical scattering.
Liver, on the other hand, is highly vascularized (veins, ducts) with densely distributed hepatic cells. The tissue structure alone could influence the efficiency of passive diffusion into interstitial compartments. In fact, our results do demonstrate, to some degree, the influence of tissue structure to clearing through different organs. Brain and colon display a sharp contrast in optical clearing with all four clearing protocol. This could be explained by the difference in tissue composition where brain possess a high level of homogeneity than colon. On the other hand, liver and brain have similar tissue composition; cells (hepatic and neuronal cells) and
high density of vasculatures, aside from sparsely distribution collagen fibers in liver.
However, liver possess larger diameter vascular networks than brain and other tissue. Our repeatable observation that 3DISCO showed excellent clearing performance above other clearing agents. This suggests that larger vascular tissue requires rapid dehydration and replacement of index matching fluid. Next, myelinated spinal tissue (high lipid content) increases optical scattering. Our results showed that both dehydration (3DISCO) and high osomatic pressure (SeeDB) promotes improved clearing in myelinated tissue as oppose to lipid disruption by urea in ScaleView. This is consistent with previous clearing experiments [14] . In the future, more efforts will be needed to look into the roles of diffusion/uptake rate of clearing agent with varying viscosity and molecular weight in the complex layers of the lower colon tissue.
Time and cost
The primary objective of this work was to compare the performance (depth, cost and time) of . These optical approaches will become more prevalent as more researchers adopt clearing techniques.
To conclude, we provide the analysis of both cost and time for different clearing agent and different tissue. In Fig.4 , we plotted the depth achieved with respect to cost and incubation time. Fig.4a shows that ScaleViewA2 is the most economical but at the much slower clearing rate. On average, 3DISCO cleared all the organs more rapidly but it was more costly. For brain tissue, glycerol achieved a relatively fast clearing time while imaging depth stayed restricted. Glycerol was found to work nicely at low cost and reasonably fast in clearing depth in brain. Our result (unpublished) also verifies that glycerol is aggressive (dissolves collagen) and lowers GFP fluorescence due to quenching. None of the clearing techniques attempted here can clear entire colon tissue for high resolution imaging. 3DISCO
achieved the deepest imaging depth, which makes it the best option for deep-tissue imaging of colon tissue. It is also good to note that clearing colon tissue with glycerol only took 20 minutes (~254 µm/h optical clearing speed). In summary, our results indicated that 3DISCO is suitable for time-constrained users, and SeeDB is suitable for users requiring an increased imaging depth at a greater cost. Both ScaleView and Glycerol are cost efficient with Scaleview achieving a deeper imaging depth in brain. This study provides sufficient information for any user to embark on the appropriate clearing protocol for their needs. correction is used to correct for additional first order spherical aberrations and defocusing [22] . The collar correction was corrected for the surface of the tissue for all imaging to ensure clear comparison of the imaging performance. A mold of the chamber was first designed in SolidWorks© and 3D printed (UpMINI 3D) as shown in Fig.5b . The negative mold is filled with a silicone (polymethylsiloxane, PDMS) solution and once the silicone solution has become firm, it is removed from the mold. Fig.5b shows the mold and the silicone chamber.
Methods
Multiphoton Microscope and sample chamber
For samples of varying sizes, different sized imaging chambers are used, ranging from 3 mm in height for spinal cord tissue up to 10 mm for half mouse brain samples. For larger tissue (e.g. liver and brain), the bottom of the chamber is coated with dental cement (Paladur, Pala)
to seal the chamber. To make the dental cement, the two components of Paladur, powder and liquid, are mixed together in a 10:6 (5:3) ratio, cause a polymerization reaction, which create a viscous fluid. This fluid hardens in an approximately 3 minute time window, giving the user time to mold the cement in the desired shape. Fig.5 c and d shows the 3D reconstruction and cross-sectional slice of whole brain tissue (GAD67-GFP knock-in mouse) cleared with SeeDB respectively.
Clearing agent
In Table 1 , we list the protocols used here, namely, glycerol, SCALE, SeeDB, 3DISCO.
Glycerol is chosen as our reference clearing agent because it is considered as one of the most basic clearing procedures available. 
Clearing Agent
Sample preparation
Samples for the experiments were:
In order to reduce variability in our samples, the organs are prepared in the following manner; 1) Mice were anesthetized using chloral hydrate (400mg/kg) or ketamine (10mg/kg)/xylazine (10mg/kg).
2) They were perfused with 4% saline for 5-10 min followed by 5 min of 4% (wt/vol) paraformaldehyde (PFA) in 0.1 M PB, using a syringe operated manually.
3) Organs of interest were dissected and post-fixed by immersion using 4% (wt/vol) PFA overnight.
4)
Organ was placed in a Petri dish with PBS and extra tissue was removed and/or sliced into required sample size.
5)
Samples was immersed in PBS and stored at 4 o C in the fridge.
Clearing protocols
Each protocol consists of basically three main steps: clearing agent preparation, sample preparation and incubation of the sample in the clearing agent; and preparation of the cleared sample for imaging. The preparation steps together with the incubation period will take up mostly of the time The protocols used in this study are based on the published protocols for SeeDB, 3DISCO and Scale [8, 9, 10] . As the equipment and resources are slightly different than that described in these papers, the protocols used here are altered according to the available laboratory equipment.
Glycerol
1) Prepare 80% glycerol/20% PBS solution.
2.4.1.1.
Tissue clearing 1) Incubate sample in 20 ml glass vial for ~1 hours in 80% glycerol solution 2) Put sample in fresh 80% glycerol solution in the imaging chamber.
3) Put imaging chamber under the microscope and acquire images.
3DISCO
1) Prepare 50%, 70%, 80%, 100% tetrahydroforan (THF) working solutions from the stock solution in 20 ml glass vials, dilute with distilled water. Mix by shaking for few minutes. 6) Store in the dark, tightly sealed at room temperature. For best results, do not use for longer than two weeks.
Tissue clearing
1) Transfer the sample directly into the 20 ml vial containing the clearing solution in accordance with Table 2 .
2) Add clearing solutions according to clearing steps described in Table 2 
4) Repeat
Step 4 until the sample has been incubated in the last immersion step for the appropriate amount of time.
5)
Put the cleared sample in the imaging chamber together with SeeDB solution.
Using the SeeDB solution in the chamber will maintain the same refractive index.
6) Place the sample under the microscope. 
